CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net loss	$ (19,376)	$ (1,109)
Adjustments:
Depreciation	52	80
Stock-based compensation expense	1,924	181
Bad debt (recoveries) expense	(124)	82
Noncash lease costs	0	230
Noncash amortization of debt discount	104	0
Noncash interest expense associated with convertible debt	243	0
Noncash change in fair value of derivatives	10,397	0
Other	12	30
Changes in operating assets and liabilities:
Accounts receivable	(198)	(502)
Prepaid expenses and other current assets	(5,970)	0
Accounts payable	1,309	(594)
Accrued expenses and other current liabilities	(2,969)	796
Deferred revenue	591	438
Net cash used in operating activities	(14,005)	(368)
Cash flows from investing activities
Purchase of property, equipment, and software	(788)	0
Net cash used in investing activities	(788)	0
Cash flows from financing activities
Proceeds from exercise of stock options	127	40
Proceeds from convertible promissory notes	29,374	0
Trust proceeds from recapitalization	582	0
Restricted cash received related to Forward Share Purchase Agreements	39,032	0
Transaction costs associated with recapitalization	(10,397)	0
Payments on related party payables	(7)	(65)
Net cash provided by (used in) financing activities	58,711	(25)
Net increase (decrease) in cash, cash equivalents, and restricted cash	43,918	(393)
Cash, cash equivalents, and restricted cash, beginning of period	28,695	4,934
Cash, cash equivalents, and restricted cash, end of period	72,613	4,541
Supplemental disclosure of non-cash financing activities
Stockholder contribution for debt issuance costs	924	0
Conversion of promissory notes into common stock	33,024	0
Forward share purchase agreements	14,170	0
Private warrants	3,916	0
Sponsor shares subject to earnout conditions	6,867	0
Stockholder earn-out rights	$ 26,131	$ 0